Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 58.29B | 57.12B | 52.77B | 44.20B | 2.42B |
Gross Profit | 37.76B | 37.23B | 34.97B | 30.01B | 1.41B |
EBITDA | 5.80B | 6.69B | 8.86B | 7.36B | -210.00M |
Net Income | 2.16B | 2.92B | 4.90B | 3.62B | -532.00M |
Balance Sheet | |||||
Total Assets | 79.09B | 77.56B | 79.95B | 74.64B | 68.35B |
Cash, Cash Equivalents and Short-Term Investments | 4.99B | 2.68B | 5.48B | 2.30B | 1.58B |
Total Debt | 36.21B | 37.99B | 42.44B | 44.26B | 41.91B |
Total Liabilities | 48.91B | 49.72B | 54.02B | 53.61B | 50.98B |
Stockholders Equity | 30.18B | 27.84B | 25.93B | 21.03B | 17.37B |
Cash Flow | |||||
Free Cash Flow | 3.97B | 3.99B | 6.82B | 3.09B | 728.00M |
Operating Cash Flow | 4.00B | 4.05B | 7.38B | 3.65B | 763.00M |
Investing Cash Flow | -545.00M | -511.00M | -981.00M | -1.55B | -33.02B |
Financing Cash Flow | -5.06B | -6.34B | -3.22B | -1.38B | 33.84B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | 67.28B | 22.89 | 22.33% | 3.66% | 10.29% | 22.04% | |
76 Outperform | 47.07B | 13.90 | 20.09% | 3.71% | 9.05% | -3.95% | |
72 Outperform | 41.54B | 20.39 | 0.00% | 2.81% | 23.00% | 25.36% | |
71 Outperform | 61.64B | 12.84 | 19.03% | 3.51% | 0.16% | -21.98% | |
70 Outperform | 46.33B | 6.70 | 11.15% | 3.25% | 12.44% | 37.34% | |
67 Neutral | ¥87.50B | 40.57 | 2.40% | 4.85% | -51.19% | ||
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
TRYT Inc. announced the successful completion of a tender offer for its common stock by TCG2505 Co., Ltd., which will result in changes to its major shareholder status. The tender offer has led to TCG2505 Co., Ltd. acquiring a significant portion of TRYT Inc.’s shares, making it a major shareholder and affecting the company’s associated companies, including TCG2504 Co., Ltd. and TCG2503 Co., Ltd.
TRYT Inc. has announced the setting of a record date for an extraordinary general meeting of shareholders, scheduled for early to mid-September 2025. This meeting is contingent upon the successful completion of a tender offer by TCG2505 Co., Ltd. If the tender offer is successful but does not result in the acquisition of all company shares, the meeting will address a reverse share split and amendments to the company’s Articles of Incorporation. The outcome could significantly impact the company’s shareholder structure, with TCG2505 Co., Ltd. and LIFE SCIENCE & DIGITAL HEALTH CO. LIMITED potentially becoming the sole shareholders.
TRYT Inc. has announced its support for a tender offer by TCG2505 Co., Ltd. to acquire all of its common stocks, with the intention of becoming a wholly-owned subsidiary and subsequent delisting. This move is backed by the Carlyle Group, a global investment company, and aims to ensure fairness and avoid conflicts of interest, potentially impacting TRYT’s market positioning and shareholder interests.
TRYT Inc. announced a revision to its dividend forecast, deciding not to pay a year-end dividend for the fiscal year ending December 31, 2025. This decision is contingent upon the successful completion of a tender offer by TCG2505 Co., Ltd., which aims to make TRYT a wholly-owned subsidiary and delist its shares.
TRYT Inc. reported its consolidated financial results for the first quarter of 2025, showing an increase in revenue by 8.2% compared to the previous year, despite operating and net losses. The company anticipates a positive outlook for the fiscal year ending December 31, 2025, with expected revenue growth of 12.6% and significant improvements in profit margins, indicating strategic efforts to enhance financial performance.